These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2588202)

  • 1. Examination of Cavinton effect in elderly diabetic patients.
    Boda J; Karsay K; Czakó L; Fügi S; Kovács A; Koncz I; Maczkó PA
    Ther Hung; 1989; 37(3):176-80. PubMed ID: 2588202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM; Shprakh VV; Savkov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):39-44. PubMed ID: 3364094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [10-year experience with using Cavinton in cerebrovascular disorders].
    Burtsev EM; Savkov VS; Shprakh VV; Burtsev ME
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):56-60. PubMed ID: 1319651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic effect of cavinton in chronic cerebral circulatory insufficiency].
    Burtsev EM; Tugutov AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(1):53-6. PubMed ID: 3984593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].
    Jonderko G; Szramek-Urbaniak A; Bednarczyk-Kałuzna M
    Przegl Lek; 1982; 39(9):617-20. PubMed ID: 7178532
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM; Shkrobot SI; Borak VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effects of prostaglandin E1 in diabetic patients].
    Taveggia G; Selletti L
    Minerva Cardioangiol; 2003 Jun; 51(3):317-22. PubMed ID: 12867884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cavinton in the therapy of cerebrovascular disorders].
    Kalvach P; Bauer J; Ságová V
    Cesk Neurol Neurochir; 1982 Nov; 45(6):380-5. PubMed ID: 7151202
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 10. [An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia].
    Vaizova OE; Vengerovskiĭ AI; Alifirova VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():46-50. PubMed ID: 18196635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant effect of cavinton in the treatment of climacteric symptoms.
    Kiss E
    Ther Hung; 1990; 38(4):170-3. PubMed ID: 2094056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
    Szapáry L; Horváth B; Alexy T; Márton Z; Késmárky G; Szóts M; Nagy F; Czopf J; Tóth K
    Orv Hetil; 2003 May; 144(20):973-8. PubMed ID: 12830727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasoactive and cardiotonic drugs in the treatment of initial manifestations of cerebrovascular insufficiency in occlusive diseases of major blood vessels of the head].
    Ishchenko MM; Dorogiĭ AN; Nechaĭ EE; Shkrobot SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(1):71-5. PubMed ID: 1647114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of cavinton forte on the cerebral hemodynamic and autoregulation mechanisms of cerebral blood flow in patients with chronic cerebral ischemia].
    Grigor'eva AN; Nesterova MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):90-1. PubMed ID: 19708280
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Shkrobot SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1338-42. PubMed ID: 4072532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trial of using Cavinton in cerebrovascular disorders].
    Shtok VN; Eremeeva SV
    Klin Med (Mosk); 1982 Oct; 60(10):39-42. PubMed ID: 6757560
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cerebral hemodynamic function in patients with the initial manifestations of brain blood supply failure under the influence of pelotherapy combined with the electrophoresis of vasoactive preparations].
    Musaev AV; Balakishieva FK
    Vopr Kurortol Fizioter Lech Fiz Kult; 1991; (4):13-6. PubMed ID: 1792718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrophoresis of vasoactive drugs in the treatment and rehabilitation of patients with cerebral ischemic diseases].
    Musaev AV; Balakishieva FK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(2):79-82. PubMed ID: 20607919
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations with cavinton treatment in acute cerebral ischaemic conditions.
    Kovács G
    Ther Hung; 1984; 32(4):155-7. PubMed ID: 6571201
    [No Abstract]   [Full Text] [Related]  

  • 20. [The characteristics of the clinical course of closed craniocerebral trauma in diabetics].
    Romodanov AP; Potapov AI; Dmitriev IA
    Zh Vopr Neirokhir Im N N Burdenko; 1991; (4):11-3. PubMed ID: 1659073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.